MoonLake Immunotherapeutics (MLTX) executive compensation, 2026 proxy

Dr. Jorge Santos da Silva, Chief Executive Officer and Interim Chair of the Board, was paid $4.9M in 2025, up 252% from $1.4M the year before. The CEO-to-median-employee pay ratio was 21:1, on median employee pay of $237,155.

Filed
April 21, 2026
Annual meeting
June 4, 2026
Pay year
2025
Named executives
3
CEO total pay
$4.9M+252% vs prior year
CEO to median employee
21:1median $237,155
CEO pay in equity
81%$4M in awards
Prior say-on-pay support
99%of votes cast
CEO Stock Awards
$4,000,021Time-based restricted shares
Say-on-Pay Support
99%2025 annual meeting
Median Employee Pay
$237,155Fiscal 2025 total compensation
CEO Pay Ratio
20.8:1Ratio for fiscal 2025

How Silva was paid

$4.9M in total for 2025, as reported in the Summary Compensation Table. Equity awards are valued at grant, not at what they turned out to be worth.

Salary15%Stock awards81%Pension and deferred comp3%All other compensation1%

Named executive officers

ExecutiveTotal
Dr. Jorge Santos da SilvaChief Executive Officer and Interim Chair of the Board$4,943,209
Matthias BodenstedtChief Financial Officer$4,692,576
Dr. Kristian ReichChief Scientific Officer$4,795,493

What changed and why

  • $4.9MCEO total compensation was $4,943,209 in fiscal 2025, compared to $1,406,038 in the prior year.
  • Base salaries for named executive officers remained unchanged for 2025.
  • Named executive officers voluntarily agreed to waive their cash bonus payouts for 2025 despite achievement of corporate goals.
  • Named executive officers received annual equity awards consisting of restricted stock or time-based stock options.
  • $237KThe CEO to median employee pay ratio for fiscal 2025 was 20.8:1 based on median employee pay of $237,155.

About this page

Figures are automated and can be wrong; check the filing for the exact numbers. Totals follow SEC rules, which value stock and option awards at grant. Read the DEF 14A proxy statement for footnotes and the compensation committee's full reasoning.